Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002004313 | SCV002296961 | uncertain significance | not provided | 2023-07-17 | criteria provided, single submitter | clinical testing | ClinVar contains an entry for this variant (Variation ID: 1505967). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt SLC12A2 protein function. This missense change has been observed in individual(s) with clinical features of autosomal dominant SLC12A2-related neurodevelopmental disorder (Invitae). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This sequence change replaces arginine, which is basic and polar, with histidine, which is basic and polar, at codon 294 of the SLC12A2 protein (p.Arg294His). |
Fulgent Genetics, |
RCV002486659 | SCV002789581 | uncertain significance | Kilquist syndrome; Hearing loss, autosomal dominant 78; Delpire-McNeill syndrome | 2022-05-20 | criteria provided, single submitter | clinical testing |